| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/13/2012 | CN102488670A Preparation method of dual slow-release potassium citrate sustained release preparation |
| 06/13/2012 | CN101744857B Bidens parviflora willd extractive, preparation method thereof and application in preparing medicines for resisting prostatic disorders |
| 06/13/2012 | CN101721363B Cefixime oral administration mixed suspension and preparation method thereof |
| 06/13/2012 | CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof |
| 06/13/2012 | CN101439039B Fortifier |
| 06/13/2012 | CN101389221B Silver/water, silver gels and silver-based compositions, method for fabricating and using the same |
| 06/13/2012 | CN101014356B Oligopeptides for reducing elevated blood urea concentration |
| 06/12/2012 | US8197813 Human antibodies that bind human TNFα |
| 06/12/2012 | CA2479549C Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 06/07/2012 | WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound |
| 06/07/2012 | WO2012048846A3 Phosphate binder formulation for simple ingestion |
| 06/07/2012 | WO2011023986A8 Kinase inhibitors |
| 06/07/2012 | US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 06/07/2012 | US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 06/07/2012 | US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2 |
| 06/07/2012 | US20120142729 KAT ll INHIBITORS |
| 06/07/2012 | US20120142725 Combined Use of an Alpha-Adrenergic Receptor Antagonist and an Anti-Muscarinic Agent |
| 06/07/2012 | US20120142716 4-pyrimidinesulfamide derivative |
| 06/07/2012 | US20120142692 Antifolate combinations |
| 06/07/2012 | US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor |
| 06/07/2012 | US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor |
| 06/07/2012 | US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators |
| 06/07/2012 | US20120142638 Combination of organic compounds |
| 06/07/2012 | US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis |
| 06/07/2012 | US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
| 06/07/2012 | US20120142595 Tissue protective peptides and uses thereof |
| 06/07/2012 | US20120141581 Capsule and powder formulations containing lanthanum compounds |
| 06/07/2012 | US20120141580 Capsule formulations containing lanthanum compounds |
| 06/07/2012 | US20120141554 Delayed release formulation for reducing the frequency of urination and method of use thereof |
| 06/07/2012 | US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders |
| 06/07/2012 | US20120141451 Fibroblast growth factor receptor-derived peptides binding to ncam |
| 06/07/2012 | US20120141449 Albumin Fusion Proteins |
| 06/07/2012 | US20120141428 Muscle-derived cells (mdcs) for treating muscle- or bone-related injury or dysfunction |
| 06/07/2012 | US20120141416 Multimeric peptide conjugates and uses thereof |
| 06/07/2012 | US20120141415 Albumin Fusion Proteins |
| 06/07/2012 | US20120141401 Soft anticholinergic zwitterions |
| 06/07/2012 | US20120141378 Methods for treating chronic kidney disease |
| 06/07/2012 | US20120138506 Methods of treatment and pharmaceutical composition |
| 06/07/2012 | CA2819854A1 Nitric oxide treatments |
| 06/06/2012 | EP2460791A1 Indole derivative and pharmacologically acceptable salt thereof |
| 06/06/2012 | EP2460787A1 Amide compounds and their use as PGE2 antagonists. |
| 06/06/2012 | EP2459572A2 Spirocyclic amide derivatives |
| 06/06/2012 | EP2459520A1 Crystalline forms of fesoterodine fumarate and fesoterodine base |
| 06/06/2012 | EP1967209B1 Therapeutic agent for prostate cancer |
| 06/06/2012 | EP1851250B1 Human monoclonal antibody to prostate specific membrane antigen (psma) |
| 06/06/2012 | CN1935839B Analogues of GLP-1 |
| 06/06/2012 | CN102485903A Method for preparing biological active protein oligopeptide powder from deer placenta |
| 06/06/2012 | CN102485255A Compound preparation used for preventing and treating nephrotic syndrome hypoproteinemia, preparation method thereof, and application thereof |
| 06/06/2012 | CN102485254A Traditional Chinese medicine composition with characteristics of clearing heat and detoxifying, cooling blood and freeing strangury as well as its preparation method |
| 06/06/2012 | CN102485253A Traditional Chinese medicine composition with characteristics of clearing heat and detoxifying, cooling blood and freeing strangury as well as its preparation method |
| 06/06/2012 | CN102058715B Chinese medicine preparation for treating chronic prostatitis and preparation method thereof |
| 06/06/2012 | CN102028890B Traditional Chinese medicine composition for treating uremia |
| 06/06/2012 | CN101953982B Traditional Chinese medicine plaster for treating chronic pyelonephritis |
| 06/06/2012 | CN101775026B Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof |
| 06/06/2012 | CN101638404B High-purity salvianolic acid B and preparation method and application thereof |
| 06/06/2012 | CN101564496B Plaster for mainly curing periarthritis of shoulder |
| 06/06/2012 | CN101274036B Method for testing conghuang preparation for tonifying kidney |
| 06/05/2012 | US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof |
| 06/05/2012 | US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof |
| 06/05/2012 | US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 06/05/2012 | CA2557275C Bicyclo derivative |
| 06/05/2012 | CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 06/05/2012 | CA2368670C Modulation of vascular permeability by means of tie2 receptor activators |
| 05/31/2012 | WO2012070621A1 Use of age-specific aptamer for treating renal disease |
| 05/31/2012 | WO2012070040A1 Compositions and methods for ameliorating renal dysfunction induced by renal hypoperfusion or acute kidney injury |
| 05/31/2012 | WO2012069402A1 Substituted cyclopentyl - azines as casr- active compounds |
| 05/31/2012 | WO2012033789A3 Treatment of diseases |
| 05/31/2012 | WO2012006634A3 Prostate specific antigen (psa) peptide therapy |
| 05/31/2012 | US20120136068 Ameliorant for renal insufficiency |
| 05/31/2012 | US20120136066 Glomerulonephritis Treatment |
| 05/31/2012 | US20120136044 Compositions And Methods Of Inhibiting NADPH Oxidase Expression |
| 05/31/2012 | US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof |
| 05/31/2012 | US20120136007 Methods and compositions for treating degenerative and ischemic disorders |
| 05/31/2012 | US20120136006 Cold menthol receptor antagonists |
| 05/31/2012 | US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives |
| 05/31/2012 | US20120136001 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 05/31/2012 | US20120135984 Dual-action inhbitors and methods of using same |
| 05/31/2012 | US20120135982 5HT2c RECEPTOR MODULATORS |
| 05/31/2012 | US20120135979 Pyrazinooxazepine derivatives |
| 05/31/2012 | US20120135971 Estrogen antagonists as treatments for sclerosing disorders |
| 05/31/2012 | US20120135964 Certain chemical entities, compositions, and methods |
| 05/31/2012 | US20120135932 Compositions And Methods For Treating Ischemia And Ischemia-Reperfusion Injury |
| 05/31/2012 | US20120135929 Methods Of Modulating Uric Acid Levels |
| 05/31/2012 | US20120135050 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 05/31/2012 | US20120134933 Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine |
| 05/30/2012 | EP2457897A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 05/30/2012 | EP1928551B1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
| 05/30/2012 | EP1702919B1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 05/30/2012 | CN202236444U Traditional Chinese medicinal powder for treating tissue disease of urinary bladder channel and packages |
| 05/30/2012 | CN202236442U Traditional Chinese medicine decoction for treating bladder meridian tissue diseases and package thereof |
| 05/30/2012 | CN202236437U Traditional Chinese medicine slurry and package combination for treating diseases of kidney channel tissues |
| 05/30/2012 | CN202236432U Prostatitis paster |
| 05/30/2012 | CN1700920B Phophylactic and therapeutic use of hydroxysteroids |
| 05/30/2012 | CN102482256A N-取代的环状氨基衍生物 N- substituted cyclic amino derivative |
| 05/30/2012 | CN102482230A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use |
| 05/30/2012 | CN102481333A Immunity inducer |
| 05/30/2012 | CN102481326A 利用华西小石积治疗和预防糖尿病并发症的组合物 Use Osteomeles schweriniae treatment and prevention of diabetic complications composition |
| 05/30/2012 | CN102481280A 发动蛋白环稳定剂的用途 Launch protein ring stabilizer uses |
| 05/30/2012 | CN102477385A 一种益肝护肾保健酒 One kind of liver and kidney health wine |